Suppr超能文献

高分辨率 CT 检查结果对 T1aN0M0 期肺癌临床病理模式和肿瘤学结局的影响

Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography.

机构信息

Department of Radiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zheng Min Road, Shanghai, 200433, China.

Shanghai Heart Failure Research Center, Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.

出版信息

Eur Radiol. 2021 Oct;31(10):7353-7362. doi: 10.1007/s00330-021-07865-2. Epub 2021 Apr 15.

Abstract

OBJECTIVES

To elucidate the clinicopathological characteristics and oncological outcomes of clinical T1aN0M0 (c-T1N0M0) lung cancer based on the newest 8th TNM classification.

METHODS

A total of 257 patients with c-T1aN0M0 lung cancer were retrospectively included in this study. According to the solid component size manifesting on the high-resolution computed tomography (HRCT), all lesions were classified as the pure ground-glass nodule (pure-GGN) with a diameter > 3 cm (n = 19), part-solid (n = 174), and pure-solid (n = 64) groups. We evaluated the prognostic impact of clinicopathologic variables including radiological presentations by establishing Cox proportional hazards model.

RESULTS

When we evaluated the prognostic impact based on the radiological subtypes, the 5-year recurrence-free survival (RFS) and overall survival (OS) were significantly different among pure-GGN, part-solid, and pure-solid groups (RFS: 100% versus 95.4% versus 76.6%, p < 0.0001; OS: 100% versus 98.9% versus 87.5%, p < 0.0001). Cox regression analysis revealed the preoperative carcinoembryonic antigen (CEA) level and consolidation tumor ratio (CTR) were independently significant prognosticators related to RFS and OS. Furthermore, a receiver operating characteristic (ROC) verified the CTR (area under ROC [AUC] 0.784, 95%CI 0.697-0.869) was equipped with good performance to predict the postoperative recurrence with a cutoff point at 0.5. Lung cancer with higher CTR tended to be associated with lower survival in the c-T1aN0M0 stage.

CONCLUSIONS

For the c-T1aN0M0 lung cancer, pulmonary nodules manifested as the pure-GGN and part-solid subtypes had an excellent prognosis and may be considered as the "early-stage" cancer, whereas those with pure-solid appearance were associated with the high risk of recurrence despite the sub-centimeter size.

KEY POINTS

• Radiological subtypes could further stratify the risk of lung cancer in cT1a. • Sub-solid nodule has a favorable survival in c-T1a lung cancer, whereas pure-solid nodule is not always "early-stage" lung cancer and is relatively prone to postoperative recurrence despite the sub-centimeter size. • The preoperative CEA level and CTR are valuable prognosticators to predict the recurrence in c-T1a lung cancer.

摘要

目的

根据最新的第 8 版 TNM 分期,阐明临床 T1aN0M0(c-T1N0M0)肺癌的临床病理特征和肿瘤学结果。

方法

本研究回顾性纳入 257 例 c-T1aN0M0 肺癌患者。根据高分辨率计算机断层扫描(HRCT)上显示的实性成分大小,所有病变均分为纯磨玻璃结节(纯 GGN)直径>3cm(n=19)、部分实性(n=174)和纯实性(n=64)组。我们通过建立 Cox 比例风险模型,评估包括影像学表现在内的临床病理变量对预后的影响。

结果

当我们根据影像学亚型评估预后影响时,纯 GGN、部分实性和纯实性组之间 5 年无复发生存率(RFS)和总生存率(OS)差异有统计学意义(RFS:100%比 95.4%比 76.6%,p<0.0001;OS:100%比 98.9%比 87.5%,p<0.0001)。Cox 回归分析显示,术前癌胚抗原(CEA)水平和实变肿瘤比(CTR)是与 RFS 和 OS 相关的独立显著预后因素。此外,受试者工作特征(ROC)验证 CTR(ROC 曲线下面积[AUC]0.784,95%CI 0.697-0.869)具有良好的预测术后复发的性能,截断点为 0.5。在 c-T1aN0M0 期,CTR 较高的肺癌患者的生存情况往往较差。

结论

对于 c-T1aN0M0 肺癌,表现为纯 GGN 和部分实性亚型的肺结节具有良好的预后,可视为“早期”癌症,而表现为纯实性的肺结节尽管体积较小,但复发风险较高。

关键要点

  1. 影像学亚型可进一步分层 cT1a 肺癌的风险。

  2. 亚实性结节在 c-T1a 肺癌中具有良好的生存预后,而纯实性结节并不总是“早期”肺癌,尽管体积较小,但术后复发相对较高。

  3. 术前 CEA 水平和 CTR 是预测 c-T1a 肺癌复发的有价值的预后因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验